The Patent Finder
C3

CareFusion 303, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Previously recorded as Cardinal Health 303, Inc. (to 2010)

883 patents currently held

28 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2026. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
134
Ending by 2030
Nov 2026
Next term end
452
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Management of pending medication orders US 9,427,520
Cited by 300 later US patents, top 1% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2027.
Ends Oct 2027 · High confidence
Also notable
Displaying Visual Elements on a Medical Device US 9,190,010
Cited by 122 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Ends Sep 2031 · High confidence
Also notable
Needleless Connector with Compressible Valve US 9,144,672
Cited by 62 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Ends Mar 2033 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 17 fees due Jan 2 to 28, 2027 · next Jan 2
  • 16 fees due Feb 4 to 28, 2027 · next Feb 4
  • 12 fees due Mar 1 to 29, 2027 · next Mar 1
  • 25 fees due Apr 1 to 30, 2027 · next Apr 1
  • 23 fees due May 3 to 28, 2027 · next May 3
  • 12 fees due Jun 3 to 30, 2027 · next Jun 3
  • 9 fees due Jul 2 to 30, 2027 · next Jul 2
  • 12 fees due Aug 2 to 27, 2027 · next Aug 2
  • 7 fees due Sep 1 to 26, 2027 · next Sep 1
  • 14 fees due Oct 2 to 30, 2027 · next Oct 2
  • 15 fees due Nov 5 to 19, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • Oct 13Assignment recorded on 1 record: Workman, Michael K. to CareFusion 303, Inc. Recorded Oct 13, 2026, executed Dec 8, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76354, frame 416.
  • Oct 12Assignment recorded on 1 record: Feith, Raymond P. to CareFusion 303, Inc. Recorded Oct 12, 2026, executed Oct 9, 2024. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76342, frame 364.
  • 30 of the patents on this record were granted since Aug 23, 2026
  • 9 terms have ended since Aug 23, 2026

What they patent

The largest of its 452 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 7,657,443Intravenous Medication Harm Index System
In force
 · High confidence
In forceHigh confidence
US 7,651,481Self-Sealing Male Connector Device with Collapsible Body
In force
 · High confidence
In forceHigh confidence
US 8,060,315Method for Measuring the Incidence of Hospital Acquired Infections
In force
 · Medium confidence
In forceMedium confidence
US 7,630,791System and Method for Storing Items and Tracking Item Usage
In force
 · High confidence
In forceHigh confidence
US 7,981,101Medical Vial Adapter with Reduced Diameter Cannula and Enlarged Vent Lumen
In force
 · High confidence
In forceHigh confidence
US 9,358,368Catheter Securement Device
In force
 · High confidence
In forceHigh confidence
US 10,092,729Catheter Securement Device
In force
 · High confidence
In forceHigh confidence
US 8,177,768Vial Adapter Having a Needle-Free Valve for Use with Vial Closures of Different Sizes
In force
 · High confidence
In forceHigh confidence
US 7,766,897Protective Priming Cap for Self-Sealing Male Luer Valve
In force
 · High confidence
In forceHigh confidence
US 11,577,021System and Method for Controlling Administration of Medical Fluid
In force
 · Medium confidence
In forceMedium confidence
10 of 883 patents shown.
Pro members see all 883.
Pro members: see all 883 patents
Also on record, not counted in the 883: 28 patents in force now held by others · 148 patents ended · 385 applications pending · 107 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited